Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,590,320 papers from all fields of science
Search
Sign In
Create Free Account
Epoetin Alfa
Known as:
Erythropoietin
, 1-165-Erythropoietin (human clone lambdaHEPOFL13 protein moiety), glycoform alpha
, EPO
Expand
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine human erythropoietin (EPO). Produced primarily…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
33 relations
1 ML Epoetin Alfa 3000 UNT/ML Injection [Procrit]
1 ML Epoetin Alfa 4000 UNT/ML Injection [Procrit]
Anemia
B-Cell Activation
Expand
Narrower (7)
Binocrit
Epoetin Alfa Hexal
Epogen
Eprex
Expand
Broader (2)
Hematinics
Recombinant Erythropoietin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Efficacy and safety of epoetin alfa in critically ill patients.
H. Corwin
,
A. Gettinger
,
+8 authors
M. Corwin
The New England journal of medicine
2007
Corpus ID: 8589837
BACKGROUND Anemia, which is common in the critically ill, is often treated with red-cell transfusions, which are associated with…
Expand
Highly Cited
2006
Highly Cited
2006
Correction of anemia with epoetin alfa in chronic kidney disease.
Ajay K. Singh
,
L. Szczech
,
+4 authors
D. Reddan
The New England journal of medicine
2006
Corpus ID: 11185471
BACKGROUND Anemia, a common complication of chronic kidney disease, usually develops as a consequence of erythropoietin…
Expand
Review
2005
Review
2005
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.
B. Leyland-Jones
,
V. Semiglazov
,
+12 authors
E. Vercammen
Journal of clinical oncology : official journal…
2005
Corpus ID: 23957070
PURPOSE To evaluate the effect on survival and quality of life of maintaining hemoglobin (Hb) in the range of 12 to 14 g/dL with…
Expand
Highly Cited
2003
Highly Cited
2003
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
M. Henke
,
R. Laszig
,
+8 authors
H. Frommhold
The Lancet
2003
Corpus ID: 22034985
Highly Cited
2001
Highly Cited
2001
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
T. Littlewood
,
E. Bajetta
,
J. Nortier
,
E. Vercammen
,
B. Rapoport
Journal of clinical oncology : official journal…
2001
Corpus ID: 24021171
PURPOSE This randomized, double-blind, placebo-controlled clinical trial assessed the effects of epoetin alfa on transfusion…
Expand
Highly Cited
2000
Highly Cited
2000
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.
M. Brines
,
P. Ghezzi
,
+5 authors
A. Cerami
Proceedings of the National Academy of Sciences…
2000
Corpus ID: 10183534
Erythropoietin (EPO), recognized for its central role in erythropoiesis, also mediates neuroprotection when the recombinant form…
Expand
Highly Cited
1998
Highly Cited
1998
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.
G. Demetri
,
M. Kris
,
J. Wade
,
L. Degos
,
D. Cella
Journal of clinical oncology : official journal…
1998
Corpus ID: 28902949
PURPOSE To evaluate prospectively the effectiveness of epoetin alfa as an adjunct to chemotherapy in patients with cancer based…
Expand
Highly Cited
1997
Highly Cited
1997
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.
J. Glaspy
,
R. Bukowski
,
D. Steinberg
,
C. Taylor
,
S. Tchekmedyian
,
S. Vadhan-Raj
Journal of clinical oncology : official journal…
1997
Corpus ID: 22323216
PURPOSE To study the impact of Procrit (epoetin alfa; Amgen Inc, Thousand Oaks, CA) on quality of life, transfusion requirements…
Expand
Highly Cited
1995
Highly Cited
1995
Purification and Characterization of Hypoxia-inducible Factor 1 (*)
Guang-lan Wang
,
G. Semenza
The Journal of Biological Chemistry
1995
Corpus ID: 41659164
Hypoxia-inducible factor 1 (HIF-1) is a DNA-binding protein that activates erythropoietin (Epo) gene transcription in Hep3B cells…
Expand
Highly Cited
1993
Highly Cited
1993
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
G. Wang
,
G. Semenza
Proceedings of the National Academy of Sciences…
1993
Corpus ID: 28961662
Transcription of the human erythropoietin (EPO) gene is activated in Hep3B cells exposed to hypoxia. Hypoxia-inducible factor 1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE